The ASUNCTIS trial evaluated asunercept’s safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.
The ASUNCTIS trial evaluated asunercept’s safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.